Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

PHASE4RecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

February 19, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Migraine Disorders
Interventions
DRUG

Qudexy XR

Extended-Release Capsule

DRUG

Placebo

Qudexy XR Matching capsules

Trial Locations (15)

25701

RECRUITING

Upsher-Smith Clinical Trial Site #9, Huntington

32789

WITHDRAWN

Upsher-Smith Clinical Trial Site #8, Orlando

33470

WITHDRAWN

Upsher-Smith Clinical Trial Site #12, Loxahatchee Groves

33620

RECRUITING

Upsher-Smith Clinical Trial Site #14, Tampa

35205

WITHDRAWN

Upsher-Smith Clinical Trial Site #5, Birmingham

39216

WITHDRAWN

Upsher-Smith Clinical Trial Site #11, Jackson

45229

RECRUITING

Upsher-Smith Clinical Trial Site #4, Cincinnati

48104

WITHDRAWN

Upsher-Smith Clinical Trial Site #2, Ann Arbor

63044

WITHDRAWN

Upsher-Smith Clinical Trial Site #10, Bridgeton

78503

WITHDRAWN

Upsher-Smith Clinical Trial Site #13, McAllen

80045

WITHDRAWN

Upsher-Smith Clinical Trials Site #3, Aurora

92093

RECRUITING

Upsher-Smith Clinical Trial Site #15, La Jolla

97239

RECRUITING

Upsher-Smith Clinical Trial Site #6, Portland

97477

RECRUITING

Upsher-Smith Clinical Trials Site #7, Springfield

06901

COMPLETED

Upsher-Smith Clinical Trial Site #1, Stamford

All Listed Sponsors
lead

Upsher-Smith Laboratories

INDUSTRY